You are on Trendlyne United States. Click here to go to India website or make United States as your default
person reading

About Elutia Inc - Ordinary Shares - Class A - Company Information, Overview, History and Profile

What does Elutia Inc - Ordinary Shares - Class A do?

Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.

Elutia Inc - Ordinary Shares - Class A Management structure

All Gross Remunerations are in USD
Dr. C. Randal Mills, PhD
Director, Chief Executive Officer and President
-
2024
Gross Remuneration
Year
Mr. Matthew B. Ferguson
Chief Financial Officer and Principal Accounting Officer
-
2024
Gross Remuneration
Year

Elutia Inc - Ordinary Shares - Class A Board of directors

All Gross Remunerations are in USD
Ms. Brigid A. Makes
Independent Director
-
2024
Gross Remuneration
Year
Dr. C. Randal Mills, PhD
Director, Chief Executive Officer and President
-
2024
Gross Remuneration
Year
Mr. Kevin Rakin
Executive Chairman of the Board
-
2024
Gross Remuneration
Year
Ms. Maybelle Jordan
Independent Director
-
2024
Gross Remuneration
Year
Mr. William Matthew Zuga
Director
-
2024
Gross Remuneration
Year
Mr. David Colpman
Independent Director
-
2024
Gross Remuneration
Year